Background: Hospital-based violence intervention programs (HVIP) aim to reduce violent-injury recidivism by providing intensive, case management services to high-risk patients who were violently injured. Although HVIP have been found effective at reducing recidivism, few studies have sought to identity how long their effects last. Additionally, prior studies have been limited by the fact that HVIP typically rely on self-report or data within their own healthcare system to identify new injuries. Our aim was to quantify the long-term recidivism rate of participants in an HVIP program using more objective and comprehensive data from a regional health information exchange (HIE). Methods: The study included 328 patients enrolled in Prescription for Hope (RxH), an HVIP, between January 2009 and August 2016. We obtained RxH participants' emergency department (ED) encounter data from a regional HIE database from the date of hospital discharge to February 2017. Our primary outcome was violent-injury recidivism rate of the RxH program. We also examined reasons for ED visits that were unrelated to violent injury. Results: We calculated a 4.4% recidivism rate based on 8 years of statewide data, containing 1,575 unique encounters. Over 96% of participants were matched in the state database. Of the 15 patients who recidivated, only 5 were admitted for their injury. Over half of new violence-related injuries were treated outside of the HVIP-affiliated trauma center. The most common reasons for ED visits were pain (718 encounters), followed by suspected complications or needing additional postoperative care (181 encounters). Substance abuse, unintentional injuries, and suicidal ideation were also frequent reasons for ED visits. Conclusion: The low, long-term recidivism rate for RxH indicates that HVIP have enduring positive effects on the majority of participants. Our results suggest HVIP may further benefit patients by partnering with organizations that work to prevent suicide, substance use disorders, and other unintentional injuries. Level of Evidence: Therapeutic study, level III. (C) 2017 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2vJcAfv
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Reuters Health News from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2rI2pFX
-
The new system cuts out the practice of “over triaging calls” and uses an algorithm to suggest to dispatchers what resources are needed fr...
-
Objective: It was hypothesized that adding dedicated afternoon rounds for patients’ families to supplement standard family support would imp...
-
International Journal of Environmental Research... Latest Results for Sleep and BreathingIntermitt... Evolutionary Biology News -- S...
-
The American Journal of Emergency Medicine from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2iKBYYz
-
Big dreams to improve EMS with a windfall of funding for safety, health and wellness, research and leadership development from EMS via xlo...
-
No abstract available from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/1ZlzU7L
-
MDPI International Journal of Molecular SciencesIJMS, Vol. 21, Pages 497: Characterization of the Soybean GmIREG Family Genes and the Funct...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου